Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Bell HN, Stockwell BR, Zou W
Through our research and clinical trials, we have used cutting-edge techniques in our treatments for more than 70 years
It is still investigational, meaning it has not yet received FDA approval and is not available on prescription
Sarrauste de Menthiere C, Chavanieu A, Grassy G, et al
In 2015, Glenmark was the first to launch the DPP4 inhibitor, Teneligliptin (Zita Plus and Ziten), followed by a FDC of Teneligliptin + Metformin (Zita-Met Plus and Ziten-M)
US$ 26.35
US$ 23.04
US$ 25.68
